The Janeway Lab (@JanewayLab) header
The Janeway Lab (@JanewayLab) profile picture

The Janeway Lab

@JanewayLab

The Janeway Lab at Dana-Farber Cancer Institute led by @janeway_MD Focusing on genomics, precision oncology, and pediatric bone sarcomas

janewaylab.dana-farber.org/
Joined January 2022
  • Tweets37
  • Following189
  • Followers260
4Media
Photo by The Janeway Lab (@JanewayLab)Photo by The Janeway Lab (@JanewayLab)Photo by The Janeway Lab (@JanewayLab)Photo by The Janeway Lab (@JanewayLab)
The Janeway Lab retweeted
Katie Janeway (@janeway_MD) profile picture
Katie Janeway@janeway_MD13 Jul 2024
New work from the @JanewayLab reporting on a pediatric cancer patient cohort sequenced @DanaFarber with 95! different cancer diagnoses. So important to share data to learn about @RareCancer rdcu.be/dNt1d
Image from Katie Janeway (@janeway_MD)
2
20
78
5,530
The Janeway Lab retweeted
Katie Janeway (@janeway_MD) profile picture
Katie Janeway@janeway_MD14 Sep 2023
It is the anniversary of our patient partnered osteosarcoma project — osproject.org — creating a clinico-genomic database for the research community to drive discovery. Patients enroll online. Consider referring your patients during #childhoodcancerawareness month
9
23
1,667
The Janeway Lab retweeted
Caralynn (@caralynneh) profile picture
Caralynn@caralynneh5 Jun 2023
Awesome getting to see Maeve from @JanewayLab and @AgentsMIB present a poster at #ASCO23!
Maeve stands in front of poster board 369

ALT Maeve stands in front of poster board 369

1
4
11
757
The Janeway Lab retweeted
Katie Janeway (@janeway_MD) profile picture
Katie Janeway@janeway_MD5 Jun 2023
⁦So happy to see work done by Maeve Smart ⁦@JanewayLab⁩ about Covid-19 infection in pediatric cancer patients at #ASCO2023
Image from Katie Janeway (@janeway_MD)
2
20
866
The Janeway Lab retweeted
Katie Janeway (@janeway_MD) profile picture
Katie Janeway@janeway_MD28 Apr 2023
Excited to present on our patient partnered research on osteosarcoma and leiomyosarcoma next month!!
This Post is from an account that no longer exists. Learn more
10
1
27
2,758
Pediatric Cancer Working Group session #AACR2023 #osteosarcoma @OSInstitute @janeway_MD @huntsmancancer @DanaFarber #MIBagents #MakeItBetter
Image from MIB Agents Osteosarcoma Alliance (@AgentsMIB)
4
16
1,315
“All authors have contributed equally to this manuscript”
Image from Brad Silberzahn (@BradSilberzahn)
463
4,689
310
122,097
The Janeway Lab retweeted
Stacy W. Gray (@stacywgray) profile picture
Stacy W. Gray@stacywgray7 Aug 2022
86% of pediatric cancer patients w extracranial solid tumors have genomic alterations that potentially impact clinical care. Important somatic sequencing results from the GAIN/iCAT2 study.Beautiful work @AlannaChurch_MD @janeway_MD @JanewayLab et al. go.nature.com/3BP9c40
Image from Stacy W. Gray (@stacywgray)
14
45
A new study published in @NatureMedicine found that 86 percent of extracranial solid tumors in pediatric patients had genomic alterations. Learn more about the findings from lead author Dr. Alanna Church @AlannaChurch_MD in @HealthDayTweets. bit.ly/3PSbW4y.
3
8
An interim report from the GAIN/iCat2 study shows that molecular profiling of pediatric solid malignancies clarifies diagnostic classifications and provides opportunities for matched targeted therapy @janeway_MD @JanewayLab @AlannaChurch_MD nature.com/articles/s41591-0…
3
10
Getting ready for my presentation 👩‍💼this afternoon at 3p ET. Please join us for this free webinar to get to know @AgentsMIB and to hear about how molecular profiling is helping #ChildhoodCancer The @NatureMedicine paper is available here: rdcu.be/cQgmj
MIB Agents Osteosarcoma Alliance (@AgentsMIB) profile pictureMIB Agents Osteosarcoma Alliance@AgentsMIB5 Jul 2022
🔬OsteoBites @AlannaChurch_MD to discuss study recently published in @NatureMedicine with @janeway_MD & many others, demonstrating the clinical utility of molecular tumor profiling for children with cancer. Join in the discussion: bit.ly/3yIwcja
Image from MIB Agents Osteosarcoma Alliance (@AgentsMIB)
1
5
13
The Janeway Lab retweeted
Katie Janeway (@janeway_MD) profile picture
Katie Janeway@janeway_MD30 Jun 2022
Excited #CCDI Molecular characterization initiative of @COGorg now enrolling #sarcoma! Molecular tumor profiling of enrolled patients @nationwidekids is similar DNA and RNA sequencing as our study just published in @NatureMedicine showing clinical benefit: nature.com/articles/s41591-0…
Image from Katie Janeway (@janeway_MD)
12
29
Replying to @notSoJunkDNA @NatureMedicine @janeway_MD @AlyaaIbraheemi @SethPinches @bdcrompton @LauraMacconaill @DFBC_PedCare @DanaFarber @BostonChildrens @JanewayLab
All of the data is available in the supplement for the manuscript. The fusions in this cohort are DNAJB1::PRKACA in fibrolamellar carcinoma, an entity beautifully described by @DrSolidTumors here: sciencedirect.com/science/ar…
1
1
4
The Janeway Lab retweeted
Katie Janeway (@janeway_MD) profile picture
Katie Janeway@janeway_MD23 Jun 2022
Replying to @AlannaChurch_MD @NatureMedicine @AlyaaIbraheemi @SethPinches @bdcrompton @LauraMacconaill @DFBC_PedCare @DanaFarber @BostonChildrens @JanewayLab
It has been great working with @AlannaChurch_MD , colleagues from 16 institutions, and patients and families on this report from the GAIN consortium/iCat2 study addressing the clinical impact of targeted NGS in pediatric solid tumors. Collaboration is key for rare cancers!
2
22
An interim report from the GAIN/iCat2 study shows that molecular profiling of pediatric solid malignancies clarifies diagnostic classifications and provides opportunities for matched targeted therapy @janeway_MD @JanewayLab, @AlannaChurch_MD nature.com/articles/s41591-0…
1
11
3
25
Replying to @NatureMedicine @AlannaChurch_MD @janeway_MD @JanewayLab
Congratulations @AlannaChurch_MD, @janeway_MD, and all!
1
2
The Janeway Lab retweeted
Michael Miller (@M_B_Miller) profile picture
Michael Miller@M_B_Miller24 Jun 2022
Replying to @AlannaChurch_MD @NatureMedicine @janeway_MD @AlyaaIbraheemi @SethPinches @bdcrompton @LauraMacconaill @DFBC_PedCare @DanaFarber @BostonChildrens @JanewayLab
Congratulations, @AlannaChurch_MD and all! Beautiful and important work that showcases the emerging importance of molecular pathology.
1
4
🔬We are so excited to talk to @janeway_MD TODAY at 3PM EDT. Join us to hear an update on a Phase 2 Trial for recurrent osteosarcoma. 👉us02web.zoom.us/webinar/regi…
MIB Agents Osteosarcoma Alliance (@AgentsMIB) profile pictureMIB Agents Osteosarcoma Alliance@AgentsMIB7 Jun 2022
👩‍⚕️The awesome @janeway_MD of @DanaFarber joins us with an "Update on OSI funded phase 2 Trial of Olaparib + Ceralasertib in Recurrent #Osteosarcoma" 🗣LIVE: Thursday, 6/9, 3:00 pm EDT, us02web.zoom.us/webinar/regi… 💫Episode brought to you buy our friends at @OSInstitute #mibagents
Image from MIB Agents Osteosarcoma Alliance (@AgentsMIB)
3
7
The Janeway Lab retweeted
Katie Janeway (@janeway_MD) profile picture
Katie Janeway@janeway_MD6 Jun 2022
#ASCO22 recap: Great to see colleagues. Fantastic work presented in pediatric and #sarcoma sessions planned by Shannon Maude and @breelynwilkyMD. Then there was the plenary experience — so honored to discuss #Ewing trial by Dr. McCabe. @GorlickRichard @doctorbish @JGladeBender
Image from Katie Janeway (@janeway_MD)
Image from Katie Janeway (@janeway_MD)
Image from Katie Janeway (@janeway_MD)
Image from Katie Janeway (@janeway_MD)
1
2
46
The Janeway Lab retweeted
Lara Davis, MD (@DrLaraDavis) profile picture
Lara Davis, MD@DrLaraDavis5 Jun 2022
They might not have gotten an #ASCO22 plenary standing ovation, but Dr McCabe and @janeway_MD deserve one from the #sarcoma community! Thank you for proving we can get high quality data in #rarecancers
This Post is from an account that no longer exists. Learn more
1
5
25
Load more